Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications.

@article{Farley2008RetrospectiveAO,
  title={Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications.},
  author={Joel F. Farley and Richard R. Cline and Jon C. Schommer and Ronald S. Hadsall and John A. Nyman},
  journal={Clinical therapeutics},
  year={2008},
  volume={30 8},
  pages={1524-39; discussion 1506-7}
}
BACKGROUND Antipsychotic medications account for more prescription expenditures in Medicaid than any other therapeutic category. This has made them an attractive target for states hoping to curtail rising expenditures. OBJECTIVE The objective of this study was to document the effects of a step-therapy prior authorization (PA) policy for atypical antipsychotic medications on: (1) Medicaid prescription expenditures among all Medicaid beneficiaries and (2) prescription and health service… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

Pharmaceutical step-therapy interventions: a critical review of the literature.

Journal of managed care pharmacy : JMCP • 2011
View 7 Excerpts
Highly Influenced

The Impact of Coverage Restrictions on Antipsychotic Utilization Among Low-Income Medicare Part D Enrollees

Administration and Policy in Mental Health and Mental Health Services Research • 2017
View 3 Excerpts

Similar Papers

Loading similar papers…